Bio-Rad earnings on deck: Can margins recover after rough 2025?

Novo NordiskA proposal seeks to remove Novo and Lilly drugs from key list in the US – will provide better protection against copies - medwatch.com

FierceBiotechAmgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data

AmgenAmgen abandons candidates for cancer, Sjögren’s syndrome over weak ph. 2 data - Fierce Biotech

Samsung Biologics(LEAD) Samsung Biologics union launches 1st general strike over pay dispute - Yonhap News Agency

Samsung BiologicsSamsung Biologics, Lilly to Launch Biotech Hub Supporting Venture Ecosystem - Seoul Economic Daily

BioPharma DiveTwo biotechs raise a combined $556M in latest spurt of IPOs

Merck & Co.Spotlight On: Merck & Co. maintains BD appetite ahead of $70B sales goal - FirstWord Pharma

Siemens HealthineersSiemens Healthineers Faces a Reckoning: Diagnostics Sale, Spin-Off Delays, and a Stock at Rock Botto - AD HOC NEWS

Samsung BiologicsSamsung Biologics union launches 1st general strike over pay dispute - The Korea Times

eLifeAdapting clinical chemistry plasma as a source for liquid biopsies

Thermo FisherHow Investors Are Reacting To Thermo Fisher Scientific (TMO) Expanding Its U.S. Bioprocess Design Center - Yahoo Finance

Novo NordiskNovo-Backed Biotech Hemab Raises $301.5 Million in Upsized IPO - Bloomberg.com